-BTG plc - Trial finds patients receiving CroFab antivenom less likely to use opioids for pain control

Press/Media

Period30 Apr 2019

Media coverage

1

Media coverage

  • Title-BTG plc - Trial finds patients receiving CroFab antivenom less likely to use opioids for pain control
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date30/04/19
    PersonsCharles Gerardo
View all 1
View less